Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Negative Predictive Value of Non-Echo-Planar Diffusion Weighted MR Imaging for the Detection of Residual Cholesteatoma Done at 9 Months After Primary Surgery Is not High Enough to Omit Second Look Surgery.

Horn RJ, Gratama JWC, van der Zaag-Loonen HJ, Droogh-de Greve KE, van Benthem PG.

Otol Neurotol. 2019 Aug;40(7):911-919. doi: 10.1097/MAO.0000000000002270.

PMID:
31219966
2.

Issue Highlights - March 2019.

Gratama JW.

Cytometry B Clin Cytom. 2019 Mar;96(2):93-95. doi: 10.1002/cyto.b.21778. No abstract available.

PMID:
30884160
3.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

Vonder M, Vliegenthart R, Kaatee MA, van der Aalst CM, van Ooijen PMA, de Bock GH, Gratama JW, Kuijpers D, de Koning HJ, Oudkerk M.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):298-304. doi: 10.1016/j.jcct.2018.02.005. Epub 2018 Mar 1.

PMID:
29551663
4.

Systematic review of the safety and efficacy of contrast injection via venous catheters for contrast-enhanced computed tomography.

Buijs SB, Barentsz MW, Smits MLJ, Gratama JWC, Spronk PE.

Eur J Radiol Open. 2017 Sep 29;4:118-122. doi: 10.1016/j.ejro.2017.09.002. eCollection 2017. Review.

5.

Coronary Artery Calcium Imaging in the ROBINSCA Trial: Rationale, Design, and Technical Background.

Vonder M, van der Aalst CM, Vliegenthart R, van Ooijen PMA, Kuijpers D, Gratama JW, de Koning HJ, Oudkerk M.

Acad Radiol. 2018 Jan;25(1):118-128. doi: 10.1016/j.acra.2017.07.010. Epub 2017 Aug 23. Review.

PMID:
28843465
6.

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.

Lamers CH, Wijers R, van Bergen CA, Somers JA, Braakman E, Gratama JW, Debets R, Falkenburg JH, Cornelissen JJ.

Blood. 2016 Oct 27;128(17):2165-2174. Epub 2016 Aug 16.

PMID:
27531680
7.

Ultrasound-guided breast-conserving surgery for early-stage palpable and nonpalpable invasive breast cancer: decreased excision volume at unchanged tumor-free resection margin.

Slijkhuis WA, Noorda EM, van der Zaag-Loonen H, Eenennaam MJ, Greve KE, Lastdrager WB, Gratama JW.

Breast Cancer Res Treat. 2016 Aug;158(3):535-41. doi: 10.1007/s10549-016-3914-9. Epub 2016 Jul 21.

PMID:
27444926
8.

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.

Onstenk W, Sieuwerts AM, Mostert B, Lalmahomed Z, Bolt-de Vries JB, van Galen A, Smid M, Kraan J, Van M, de Weerd V, Ramírez-Moreno R, Biermann K, Verhoef C, Grünhagen DJ, IJzermans JN, Gratama JW, Martens JW, Foekens JA, Sleijfer S.

Oncotarget. 2016 Sep 13;7(37):59058-59069. doi: 10.18632/oncotarget.10175.

9.

Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview.

Lamers CH, Klaver Y, Gratama JW, Sleijfer S, Debets R.

Biochem Soc Trans. 2016 Jun 15;44(3):951-9. doi: 10.1042/BST20160037.

PMID:
27284065
10.

Issue highlights - May 2016.

Gratama JW.

Cytometry B Clin Cytom. 2016 May;90(3):244-6. doi: 10.1002/cyto.b.21379. No abstract available.

11.

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.

Reijm EA, Sieuwerts AM, Smid M, Vries JB, Mostert B, Onstenk W, Peeters D, Dirix LY, Seynaeve CM, Jager A, de Jongh FE, Hamberg P, van Galen A, Kraan J, Jansen MP, Gratama JW, Foekens JA, Martens JW, Berns EM, Sleijfer S.

BMC Cancer. 2016 Feb 18;16:123. doi: 10.1186/s12885-016-2155-y.

12.

Hip Resurfacing Implant Orientation Analysis: A Comparison of a Computer-Added Design Technique and Computed Tomography.

Weenders SG, van de Kimmenade RJ, Gratama JW, van der Zaag-Loonen HJ, Bullens PH, Breemans E.

J Arthroplasty. 2016 Feb;31(2):501-5. doi: 10.1016/j.arth.2015.08.042. Epub 2015 Sep 9.

PMID:
26427940
13.

Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward.

Preijers FW, van der Velden VH, Preijers T, Brooimans RA, Marijt E, Homburg C, van Montfort K, Gratama JW; Section Immunological and Molecular Cell Diagnostics of the Foundation for Quality Assessment in Medical Laboratories(SKML).

Cytometry B Clin Cytom. 2016 May;90(3):267-78. doi: 10.1002/cyto.b.21266. Epub 2015 Jul 31.

14.

Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial.

Beije N, Kraan J, Taal W, van der Holt B, Oosterkamp HM, Walenkamp AM, Beerepoot L, Hanse M, van Linde ME, Otten A, Vernhout RM, de Vos FY, Gratama JW, Sleijfer S, van den Bent MJ.

Br J Cancer. 2015 Jul 14;113(2):226-31. doi: 10.1038/bjc.2015.191. Epub 2015 Jun 4.

15.

[Referral for mammography often not according to guideline].

Lodder-van der Vlies D, Droogh-de Greve K, de Win JL, van der Zaag-Loonen HJ, van Bruggen JA, Markestein HP, Gratama JW.

Ned Tijdschr Geneeskd. 2015;159:A8636. Dutch.

PMID:
25804111
16.

Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.

Onstenk W, Sieuwerts AM, Weekhout M, Mostert B, Reijm EA, van Deurzen CH, Bolt-de Vries JB, Peeters DJ, Hamberg P, Seynaeve C, Jager A, de Jongh FE, Smid M, Dirix LY, Kehrer DF, van Galen A, Ramirez-Moreno R, Kraan J, Van M, Gratama JW, Martens JW, Foekens JA, Sleijfer S.

Cancer Lett. 2015 Jun 28;362(1):36-44. doi: 10.1016/j.canlet.2015.03.020. Epub 2015 Mar 19.

PMID:
25797316
17.

Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.

Beije N, Versluis J, Kraan J, Gratama JW, Sleijfer S, Cornelissen JJ.

Haematologica. 2015 Jun;100(6):e246-9. doi: 10.3324/haematol.2014.121731. Epub 2015 Feb 20. No abstract available.

18.

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Mostert B, Sieuwerts AM, Bolt-de Vries J, Kraan J, Lalmahomed Z, van Galen A, van der Spoel P, de Weerd V, Ramírez-Moreno R, Smid M, Verhoef C, IJzermans JN, Gratama JW, Sleijfer S, Foekens JA, Martens JW.

Mol Oncol. 2015 Apr;9(4):920-32. doi: 10.1016/j.molonc.2015.01.001. Epub 2015 Jan 21.

19.

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases.

Lalmahomed ZS, Mostert B, Onstenk W, Kraan J, Ayez N, Gratama JW, Grünhagen D, Verhoef C, Sleijfer S.

Br J Cancer. 2015 Feb 3;112(3):556-61. doi: 10.1038/bjc.2014.651. Epub 2015 Jan 6.

20.

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Onstenk W, Kraan J, Mostert B, Timmermans MM, Charehbili A, Smit VT, Kroep JR, Nortier JW, van de Ven S, Heijns JB, Kessels LW, van Laarhoven HW, Bos MM, van de Velde CJ, Gratama JW, Sieuwerts AM, Martens JW, Foekens JA, Sleijfer S.

Mol Cancer Ther. 2015 Mar;14(3):821-7. doi: 10.1158/1535-7163.MCT-14-0653. Epub 2014 Dec 31.

21.

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients.

Mostert B, Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, van Galen A, Peeters DJ, Dirix LY, Seynaeve CM, Jager A, de Jongh FE, Hamberg P, Stouthard JM, Kehrer DF, Look MP, Smid M, Gratama JW, Foekens JA, Martens JW, Sleijfer S.

Ann Oncol. 2015 Mar;26(3):510-6. doi: 10.1093/annonc/mdu557. Epub 2014 Dec 3.

PMID:
25471333
22.

A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

de Jongste AH, van Gelder T, Bromberg JE, de Graaf MT, Gratama JW, Schreurs MW, Hooijkaas H, Sillevis Smitt PA.

Neuro Oncol. 2015 Jan;17(1):145-50. doi: 10.1093/neuonc/nou126. Epub 2014 Jul 3.

23.

Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.

Kraan J, van den Broek P, Verhoef C, Grunhagen DJ, Taal W, Gratama JW, Sleijfer S.

Br J Cancer. 2014 Jul 8;111(1):149-56. doi: 10.1038/bjc.2014.286. Epub 2014 Jun 3.

24.

Accuracy and interobserver agreement between MR-non-expert radiologists and MR-experts in reading MRI for suspected appendicitis.

Leeuwenburgh MM, Wiarda BM, Jensch S, van Es HW, Stockmann HB, Gratama JW, Cobben LP, Bossuyt PM, Boermeester MA, Stoker J; OPTIMAP Study group.

Eur J Radiol. 2014 Jan;83(1):103-10. doi: 10.1016/j.ejrad.2013.09.022. Epub 2013 Oct 8.

25.

Tumor heterogeneity makes AML a "moving target" for detection of residual disease.

Zeijlemaker W, Gratama JW, Schuurhuis GJ.

Cytometry B Clin Cytom. 2014 Jan;86(1):3-14. doi: 10.1002/cyto.b.21134. Epub 2013 Oct 21. Review.

26.

Tumor heterogeneity makes AML a "moving target" for detection of residual disease.

Zeijlemaker W, Gratama JW, Schuurhuis GJ.

Cytometry B Clin Cytom. 2013 Oct 5. doi: 10.1002/cytob.21134. [Epub ahead of print]

27.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ.

J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23.

PMID:
24062400
28.

MRI features associated with acute appendicitis.

Leeuwenburgh MM, Jensch S, Gratama JW, Spilt A, Wiarda BM, Van Es HW, Cobben LP, Bossuyt PM, Boermeester MA, Stoker J; OPTIMAP study group.

Eur Radiol. 2014 Jan;24(1):214-22. doi: 10.1007/s00330-013-3001-0. Epub 2013 Sep 8.

PMID:
24013847
29.

Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting.

Feller N, van der Velden VH, Brooimans RA, Boeckx N, Preijers F, Kelder A, de Greef I, Westra G, Te Marvelde JG, Aerts P, Wind H, Leenders M, Gratama JW, Schuurhuis GJ.

Blood Cancer J. 2013 Aug 2;3:e129. doi: 10.1038/bcj.2013.27.

30.

What's happening under the diaphragm?

Smolders S, Gratama JW, Spronk PE, Braber A.

Neth J Med. 2013 Apr;71(3):139, 143. No abstract available.

31.

Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.

Onstenk W, Gratama JW, Foekens JA, Sleijfer S.

Cancer Treat Rev. 2013 Nov;39(7):691-700. doi: 10.1016/j.ctrv.2013.04.001. Epub 2013 May 16. Review.

PMID:
23683721
32.

Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage.

de Jongste AH, Kraan J, van den Broek PD, Brooimans RA, Bromberg JE, van Montfort KA, Smitt PA, Gratama JW.

Cytometry B Clin Cytom. 2014 Jul;86(4):272-9. doi: 10.1002/cyto.b.21097. Epub 2013 May 14.

33.

Elevated numbers of regulatory T cells, central memory T cells and class-switched B cells in cerebrospinal fluid of patients with anti-Hu antibody associated paraneoplastic neurological syndromes.

de Jongste AH, de Graaf MT, van den Broek PD, Kraan J, Smitt PA, Gratama JW.

J Neuroimmunol. 2013 May 15;258(1-2):85-90. doi: 10.1016/j.jneuroim.2013.02.006. Epub 2013 Apr 5.

PMID:
23566401
34.

Comparison of imaging strategies with conditional contrast-enhanced CT and unenhanced MR imaging in patients suspected of having appendicitis: a multicenter diagnostic performance study.

Leeuwenburgh MM, Wiarda BM, Wiezer MJ, Vrouenraets BC, Gratama JW, Spilt A, Richir MC, Bossuyt PM, Stoker J, Boermeester MA; OPTIMAP Study Group.

Radiology. 2013 Jul;268(1):135-43. doi: 10.1148/radiol.13121753. Epub 2013 Mar 12.

PMID:
23481162
35.

Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.

Lamers CH, Sleijfer S, van Steenbergen S, van Elzakker P, van Krimpen B, Groot C, Vulto A, den Bakker M, Oosterwijk E, Debets R, Gratama JW.

Mol Ther. 2013 Apr;21(4):904-12. doi: 10.1038/mt.2013.17. Epub 2013 Feb 19.

36.

Effector memory and late memory T cells accumulate in the blood of CMV-carrying individuals but not in their cerebrospinal fluid.

de Jongste AH, de Graaf MT, van den Broek PD, Kraan J, Sillevis Smitt PA, Gratama JW.

Cytometry B Clin Cytom. 2013 Jul-Aug;84(4):218-21. doi: 10.1002/cyto.b.21073. Epub 2013 Feb 7.

37.

Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.

Lamers CH, van Elzakker P, van Steenbergen SC, Luider BA, Groot C, van Krimpen BA, Vulto A, Sleijfer S, Debets R, Gratama JW.

Cytotherapy. 2013 May;15(5):620-6. doi: 10.1016/j.jcyt.2012.12.006. Epub 2013 Feb 4.

PMID:
23388583
38.

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.

Mostert B, Jiang Y, Sieuwerts AM, Wang H, Bolt-de Vries J, Biermann K, Kraan J, Lalmahomed Z, van Galen A, de Weerd V, van der Spoel P, Ramírez-Moreno R, Verhoef C, Ijzermans JN, Wang Y, Gratama JW, Foekens JA, Sleijfer S, Martens JW.

Int J Cancer. 2013 Jul;133(1):130-41. doi: 10.1002/ijc.27987. Epub 2013 Feb 9.

39.

Clinical cytometry in Europe, 2012.

Kappelmayer J, Rawstron A, Szöllosi J, Gratama JW.

Cytometry B Clin Cytom. 2012 Nov;82(6):372-3. doi: 10.1002/cyto.b.21049. No abstract available.

40.

Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.

Somers JA, Brand A, van Hensbergen Y, Mulder A, Oudshoorn M, Sintnicolaas K, Gratama JW, Falkenburg JH, Braakman E, Cornelissen JJ.

Biol Blood Marrow Transplant. 2013 Feb;19(2):266-73. doi: 10.1016/j.bbmt.2012.09.022. Epub 2012 Oct 3.

41.

Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study.

de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC.

Cancer. 2012 Dec 1;118(23):6005-11. doi: 10.1002/cncr.27613. Epub 2012 Jun 26.

42.

Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.

de Jongste AH, de Graaf MT, Martinuzzi E, van den Broek PD, Kraan J, Lamers CH, Mallone R, Gratama JW, Sillevis Smitt PA.

Neuro Oncol. 2012 Jul;14(7):841-8. doi: 10.1093/neuonc/nos118. Epub 2012 May 15.

43.

A case of abdominal tamponade.

Saltzherr TP, Lalezari F, Gratama JW, Spronk PE.

Neth J Med. 2012 Apr;70(3):139, 142. No abstract available.

44.

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients.

Kraan J, Strijbos MH, Sieuwerts AM, Foekens JA, den Bakker MA, Verhoef C, Sleijfer S, Gratama JW.

J Thromb Haemost. 2012 May;10(5):931-9. doi: 10.1111/j.1538-7836.2012.04681.x.

45.

Clinical value of circulating endothelial cell detection in oncology.

Kraan J, Sleijfer S, Foekens JA, Gratama JW.

Drug Discov Today. 2012 Jul;17(13-14):710-7. doi: 10.1016/j.drudis.2012.01.011. Epub 2012 Jan 24. Review.

PMID:
22306349
46.

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.

Mostert B, Kraan J, Sieuwerts AM, van der Spoel P, Bolt-de Vries J, Prager-van der Smissen WJ, Smid M, Timmermans AM, Martens JW, Gratama JW, Foekens JA, Sleijfer S.

Cancer Lett. 2012 Jun 1;319(1):49-55. doi: 10.1016/j.canlet.2011.12.031. Epub 2011 Dec 24.

PMID:
22202642
47.

Clinical Cytometry on both sides of the Atlantic, 2011.

Preffer FI, Gratama JW.

Cytometry B Clin Cytom. 2011 Nov;80(6):373-4. doi: 10.1002/cyto.b.20626. No abstract available.

48.

Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.

Wils EJ, van der Holt B, Broers AE, Posthumus-van Sluijs SJ, Gratama JW, Braakman E, Cornelissen JJ.

Haematologica. 2011 Dec;96(12):1846-54. doi: 10.3324/haematol.2011.047696. Epub 2011 Aug 22.

49.

Flow cytometric characterization of cerebrospinal fluid cells.

de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW.

Cytometry B Clin Cytom. 2011 Sep;80(5):271-81. doi: 10.1002/cyto.b.20603. Epub 2011 May 12. Review.

50.

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW.

Clin Cancer Res. 2011 Jun 1;17(11):3600-18. doi: 10.1158/1078-0432.CCR-11-0255. Epub 2011 Apr 19.

Supplemental Content

Loading ...
Support Center